The court docket in Alnylam's lipid patent case against Pfizer, which ended in a judgment of noninfringement in 2025.
CASE CLOSED
The court docket in Alnylam's lipid patent case against Pfizer, which ended in a judgment of noninfringement in 2025.
The court docket in Alnylam's lipid patent case against Pfizer, which ended in a judgment of noninfringement in 2025.
CASE CLOSED
The court docket in Alnylam's lipid patent case against Pfizer, which ended in a judgment of noninfringement in 2025.